Neuromuscular

The NeurologyLive® neuromuscular disease clinical focus page offers updates and information related to the clinical care and management of individuals with neuromuscular diseases such as amyotrophic lateral sclerosis, Duchenne muscular dystrophy, cerebral palsy, and spinal muscular atrophy, as well as rare diseases. This page consists of news, podcasts, and videos about the latest FDA actions, clinical guideline updates, interviews with physicians, study and clinical trial findings, and more.

Check out some of NeurologyLive®'s featured content in the carousel below.

Latest News

Post-Hoc Analysis of ADAPT Reveals Several Subgroup Responders to Efgartigimod
Post-Hoc Analysis of ADAPT Reveals Several Subgroup Responders to Efgartigimod

March 21st 2023

Efgartigimod-treated patients consistently outperformed placebo regardless of concomitant medication, thymectomy status, and timing of diagnosis.

Post-Hoc Analysis of CHAMPION MG Study Highlights Ravulizumab’s Effects on Specific Muscle Domains
Post-Hoc Analysis of CHAMPION MG Study Highlights Ravulizumab’s Effects on Specific Muscle Domains

March 21st 2023

FDA Potentially Mulling Neurofilament Light as Critical Biomarker in Upcoming AdComm Meeting of Tofersen
FDA Potentially Mulling Neurofilament Light as Critical Biomarker in Upcoming AdComm Meeting of Tofersen

March 20th 2023

Supplementing N-163 Beta Glucan Shows Disease-Modifying Effects as Adjuvant in Duchenne Muscular Dystrophy
Supplementing N-163 Beta Glucan Shows Disease-Modifying Effects as Adjuvant in Duchenne Muscular Dystrophy

March 20th 2023

Minor Differences in Inclusion Criteria, Baseline Characteristics Impact Motor and Nonmotor Clinical Outcomes in Presymptomatic Spinal Muscular Atrophy
Minor Differences in Inclusion Criteria, Baseline Characteristics Impact Motor and Nonmotor Clinical Outcomes in Presymptomatic Spinal Muscular Atrophy

March 20th 2023

Video Series
Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.